Iverlin Tablet contains Ivermectin 12mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. This medication is effective against a broad spectrum of parasites including those responsible for onchocerciasis, strongyloidiasis, scabies, and certain types of intestinal worms. Iverlin Tablet is indicated for the treatment of infections caused by susceptible parasites in both adults and children, with dosage and duration determined by the specific condition and patient weight. It is generally well-tolerated, but adverse effects may include mild gastrointestinal disturbances, dizziness, and transient skin reactions. Iverlin should be used cautiously in patients with impaired liver function or neurological disorders. It is contraindicated in individuals with known hypersensitivity to ivermectin or any of the tablet’s excipients. Proper diagnosis and adherence to prescribed dosing regimens are essential to ensure efficacy and minimize resistance development. Iverlin Tablet should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.